| abstract |
Compounds and pharmaceutically accept-able salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical composi-tions, methods of treatment, methods of synthesis, and in-termediates are also disclosed. |